Y. Yang et al. / Journal of Molecular Catalysis A: Chemical 296 (2008) 9–17
15
4.2.6. 2-(3,5-Diphenylpyrazol-1-yl)-9-phenyl-
H-5, H-6), 7.53–7.50 (m, 3H, Ph-H), 7.44 (t, J = 7.4 Hz, 2H), 7.35 (t,
J = 7.4 Hz, 1H, Ph-H), 7.09–7.07 (m, 3H, Ph-H, Mes-ArH), 6.97 (s, 1H,
Mes-ArH), 6.83 (s, 1H, H-4ꢀ), 2.38 (s, 3H, CH3), and 1.97 (s, 6H, CH3).
Anal. Calcd for C36H28N4: C 83.69, H 5.46, N 10.84; Found C, 83.45,
H 5.51, and N 10.95%.
1,10-phenanthroline (L6)
Pale yellow solid (56%). mp: 204–205 ◦C. ESI-MS: m/z 475.4
[M+H]+. 1H NMR: 8.35 (d, J = 8.4 Hz, 1H, H-4), 8.27–8.23 (t, J = 8.8 Hz,
2H, Ph-H), 8.04–7.98 (m, 3H, H-3, H-7, H-8), 7.93–7.91 (m, 2H, Ph-
o-H), 7.79 (s, 2H, H-5, H-6), 7.68 (dd, J = 7.2, 1.2 Hz, 2H, Ph-m-H),
7.51–7.45 (m, 5H, Ph-H), 7.39–7.27 (m, 5H, Ph-H), and 6.94 (s, 1H,
H-4ꢀ). Anal. Calcd for C33H22N4: C 83.52, H 4.67, N 11.81; Found C
83.43, H 4.43, and N 11.55%.
4.3. Synthesis of the nickel complexes
The nickel(II) complexes were synthesized by the following gen-
eral procedure: a solution of the ligand in THF was added to an
equimolar amount of NiCl2·6H2O or NiBr2·6H2O in THF. The reac-
tion mixture was stirred at room temperature for 12 h. The resultant
precipitate was collected, washed with THF and diethyl ether, and
dried in vacuum. All of the complexes were prepared in high yield
in this manner.
4.2.7. 2-(3,5-Dimethylpyrazol-1-yl)-9-(1-naphthyl)-
1,10-phenanthroline (L7)
Pale yellow solid (57%). mp: 178–179 ◦C. ESI-MS: m/z 401.3
[M+H]+. 1H NMR: 8.69 (d, J = 8.4 Hz, 1H, H-4), 8.40–8.30 (m, 3H,
Nap-H, H-7), 8.00-7.95 (m, 3H, Nap-H, H-8), 7.84 (d, J = 4.4 Hz, 3H,
H-5, H-6, H-3), 7.64–7.47 (m, 3H, Nap-H), 6.00 (s, 1H, H-4ꢀ), 2.93 (s,
3H, CH3), and 2.32 (s, 3H, CH3). Anal. Calcd for C27H20N4: C 80.97,
H 5.03, N 13.99; Found C 80.90, H 4.74, and N 13.76%.
[NiCl2(L1)] (1a). Light green powder (96.9%). Mp: > 300 ◦C. IR
(KBr, ꢀ/cm−1): 3050, 2919, 1613, 1584, 1569, 1459, 1432, 1416, 1385,
1367, 1332, 1128, 1070, 985, 848, 757, 734, and 649. Anal. Calcd for
4.2.8. 2-(3-Methyl-5-phenylpyrazol-1-yl)]-9-
C17 H14 N4NiCl2 (403.92): C 50.55, H 3.49, N 13.87; Found: C 50.36,
H 3.28, and N 13.48%.
(1-naphthyl)-1,10-phenanthroline (L8)
Pale yellow solid (52%). mp: 181–182 ◦C. ESI-MS: m/z [M+H]+
463.4. 1H NMR: 8.29 (dd, J = 8.8, 8.0 Hz, 2H, Nap-H), 8.02 (d,
J = 8.4 Hz, H-4), 7.95 (t, J = 7.4 Hz, 3H, H-7, Nap-H), 7.88–7.80 (m, 3H,
H-5, H-6, H-8), 7.65–7.56 (m, 2H, H-3, Nap-H), 7.52–7.40 (m, 4H,
Nap-H, 2Ph-H), 7.06 (t, J = 7.6 Hz, 2H, Ph-H), 6.99 (t, J = 7.4 Hz, 1H, Ph-
H), 6.31 (s, 1H, H-4ꢀ), and 2.39 (s, 3H, CH3). Anal. Calcd for C32H22N4:
C 83.09, H 4.79, N 12.11; Found C 83.30, H 4.74, and N 11.94%.
[NiCl2(L2)] (2a). Light green powder (97.2%). Mp: > 300 ◦C. IR
(KBr, ꢀ/cm−1): 3055, 2921, 1611, 1563, 1463, 1431, 1403, 1363, 1329,
1201, 1141, 1032, 978, 885, 854, 776, 764, 738, 702, and 649. Anal.
Calcd for C22H16 N4NiCl2 (465.99): C 56.70, H 3.46, N 12.02; Found:
C 56.92, H 3.54, and N 11.77%.
[NiCl2(L3)] (3a). Light green powder (94.0%). Mp: > 300 ◦C. IR
(KBr, ꢀ/cm−1): 3053, 2920, 2871, 1613, 1588, 1558, 1497, 1462, 1433,
1404, 1332, 1152, 977, 851, 761, 733, 700, and 651. Anal. Calcd for
4.2.9. 2-(3,5-Diphenylpyrazol-1-yl)-9-(1-naphthyl)-
C27H18 N4NiCl2 (528.06): C 61.41, H 3.44, N 10.61; Found: C 61.02, H
3.25, and N 10.25%.
1,10-phenanthroline (L9)
Pale yellow solid (42%). mp: 189–190 ◦C. ESI-MS: m/z 525.7
[M+H]+. 1H NMR: 8.37 (d, J = 8.8 Hz, 2H, Nap-H), 8.29 (d, J = 8.0 Hz,
2H, Nap-H), 8.14 (d, J = 8.8 Hz, H-4), 8.07 (d, J = 8.0 Hz, H-7), 7.97
(t, J = 7.6 Hz, 4H, H-5, H-6, H-3, H-8), 7.88 (t, J = 7.6 Hz, 3H, Nap-
H), 7.65 (t, J = 7.8 Hz, 3H, Nap-H), 7.57–7.37 (m, 7H, Ph-H, Nap-H),
7.34 (t, J = 7.0 Hz, 1H, Ph-H), 7.09 (t, J = 7.6 Hz, 2H, Ph-H), 7.00
(t, J = 7.2 Hz, 1H, Ph-H), and 6.83 (s, 1H, H-4ꢀ). Anal. Calcd for
[NiCl2(L4)] (4a). Yellow powder (93.4%). Mp: > 300 ◦C. IR (KBr,
ꢀ/cm−1): 3051, 2920, 1621, 1578, 1561, 1499, 1443, 1425, 1364, 1336,
1131, 984, 858, 778, 740, 704, and 655. Anal. Calcd for C23H18 N4NiCl2
(480.01): C 57.55, H 3.78, N 11.67; Found: C 57.21, H 3.90, and N
11.49%.
[NiCl2(L5)] (5a). Yellow powder (92.2%). Mp: > 300 ◦C. IR (KBr,
ꢀ/cm−1): 3053, 2923, 2853, 1622, 1593, 1574, 1510, 1498, 1443,
1426, 1380, 1363, 1335, 1143, 1034, 978, 860, 760, 741, 701, and 654.
Anal. Calcd for C28H20N4NiCl2 (542.08): C 62.04, H 3.72, N 10.34;
Found: C 62.36, H 3.58, and N 10.03%.
C37H24N4: C 84.71, H 4.61, N 10.68; Found C 85.02, H 4.38,
and N 10.39%.
4.2.10. 2-(3,5-Dimethylpyrazol-1-yl)-9-mesityl-
[NiCl2(L6)] (6a). Yellow powder (93.0%). Mp: > 300 ◦C. IR (KBr,
ꢀ/cm−1): 3055, 2922, 2852, 1622, 1611, 1593, 1571, 1497, 1457, 1426,
1363, 1337, 1154, 979,862, 771, 761, 740, 701, and 657. Anal. Calcd
for C33H22N4NiCl2 (604.15): C 65.60, H 3.67, N 9.27; Found: C 65.98,
H 3.82, and N 9.13%.
1,10-phenanthroline (L10
)
Pale yellow solid (52%). mp: 219–220 ◦C. ESI-MS: m/z 393.5
[M+H]+. 1H NMR: 8.28 (m, 3H, H-4, H-7, H-8), 7.81 (s, 2H, H-5, H-6),
7.59 (d, J = 8.0 Hz, 1H, H-3), 6.98 (s, 2H, Ph-m-H), 6.02 (s, 1H, H-4ꢀ),
2.91 (s, 3H, CH3), 2.36 (s, 3H, CH3), 2.32 (s, 3H, CH3), and 2.18 (s, 6H,
CH3). Anal. Calcd for C26H24N4: C 79.56, H 6.16, N 14.27; Found C
79.27, H 6.14, and N 13.81%.
[NiCl2(L7)] (7a). Light yellow powder (95.3%). Mp: > 300 ◦C. IR
(KBr, ꢀ/cm−1): 3050, 2922, 2853, 1621, 1580, 1560, 1499, 1456,
1425, 1362, 1336, 983, 860, 781, 757, and 664. Anal. Calcd for
C27H20N4NiCl2 (530.07): C 61.18, H 3.80, N 10.57; Found: C 60.90,
4.2.11. 2-(3-Methyl-5-phenylpyrazol-1-yl)-9-mesityl-
H 3.62, and N 10.41%.
1,10-phenanthroline (L11
)
[NiCl2(L8)] (8a). Light yellow powder (93.0%). Mp: > 300 ◦C. IR
(KBr, ꢀ/cm−1): 3054, 2924, 1623, 1591, 1577, 1499, 1442, 1426, 1360,
1336, 972, 900, 864, 782, 761, and 701. Anal. Calcd for C32H22N4NiCl2
(592.14): C 64.91, H 3.74, N 9.46; Found: C 64.97, H 4.02, and N 9.52%.
[NiCl2(L9)] (9a). Yellow powder (90.4%). Mp: > 300 ◦C. IR (KBr,
ꢀ/cm−1): 3055, 2923, 2853, 1622, 1592, 1575, 1495, 1458,
1426, 1362, 1336, 973, 901, 863, 774, and 700. Anal. Calcd for
C37H24N4NiCl2 (654.21): C 67.93, H 3.70, N 8.56; Found: C 68.17,
H 3.49, and N 8.51%.
Pale yellow solid (48%). mp: 202–203 ◦C. ESI-MS: m/z 455.4
[M+H]+. 1H NMR: 8.27 (d, J = 8.8 Hz, H-4), 8.35 (d, J = 8.0 Hz, H-7),
7.81 (t, J = 4.8 Hz, 3H, H-5, H-6, H-8), 7.51 (d, J = 7.84 Hz, 1H, H-3),
7.42 (m, 2H, Ph-H), 7.08 (d, J = 2.8 Hz, 3H, Ph-o-H, Ph-p-H), 6.96 (s,
2H, Mes-ArH), 6.32 (s, 1H, H-4ꢀ), 2.39 (s, 3H, CH3), 2.37 (s, 3H, CH3),
2.25 (s, 3H, CH3), and 1.96 (s, 3H, CH3). Anal. Calcd for C31H26N4: C
81.90, H 5.70, N, 12.33; Found C 81.75, H 5.44, and N 12.55%.
4.2.12. 2-(3,5-Diphenylpyrazol-1-yl)-9-mesityl-
[NiCl2(L10)] (10a). Light yellow powder (92.8%). Mp: > 300 ◦C.
IR (KBr, ꢀ/cm−1): 3054, 2920, 2854, 1615, 1580, 1562, 1505, 1457,
1425, 1365, 1335, 987, 897, 858, 775, 751, and 701. Anal. Calcd for
C26H24N4NiCl2 (522.09): C 59.81, H 4.63, N 10.73; Found: C 59.51,
H 4.67, and N 10.36%.
1,10-phenanthroline (L12
)
Pale yellow solid (41%). mp: 192 ◦C. ESI-MS: m/z 517.4 +. 1H NMR:
8.35 (d, J = 8.8 Hz, 1H, H-4), 8.23 (d, J = 8.0 Hz, 1H, H-7), 8.06 (d,
J = 8.4 Hz, 1H, H-8), 7.96 (dd, J = 1.6, 6.8 Hz, 2H, H-3), 7.83 (s, 2H,